Epinephrine
Intranasal epinephrine spray outcomes comparable with autoinjectors
SAN ANTONIO — An epinephrine nasal spray achieved pharmacokinetic and pharmacodynamic outcomes comparable with manual administration, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Top news of January: Tick bites and alpha-gal syndrome, benefits of dogs, more
Healio compiled the most-read news in allergy, asthma and immunology posted in January.
Q&A: Epinephrine nasal spray offers advantages for caregivers, patients
The FDA has accepted a new drug application for neffy, an intranasal epinephrine spray from ARS Pharmaceuticals designed to treat type I allergic reactions without an injection among adults and children who weigh 30 kg or more.
Epinephrine nasal spray achieves pharmacodynamic responses comparable with injections
Intranasal epinephrine produced pharmacodynamic results that were comparable with or higher than autoinjectors and manual injection, according to a study published in Annals of Allergy, Asthma & Immunology.
Previous reaction severity associated with epinephrine use in home oral immunotherapy
The severity of previous reactions can predict the potential need for epinephrine treatment during home administration of OIT for food allergy, according to a study published in Annals of Allergy, Asthma & Immunology.
Top 10 asthma, allergy stories of 2022
Researchers continued to investigate how to help allergy and asthma patients breathe easier, eat better, and live safer and more satisfying lives in 2022. Here are our top 10 stories about these developments this year.
Racial disparities found in food allergy anaphylaxis awareness, education
LOUISVILLE, Ky. — There is an education gap pertaining to anaphylaxis among Black individuals with food allergy, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Multi-allergen oral immunotherapy may save time, but increases epinephrine use
LOUISVILLE, Ky. — Multi-allergen oral immunotherapy may reduce treatment time overall but also led to significant increases in epinephrine use compared with single-allergen oral immunotherapy, according to study results.
Sublingual epinephrine film rivals intramuscular injection delivery times, concentrations
LOUISVILLE, Ky. — A sublingual film delivered sufficient concentrations of epinephrine to the blood faster than autoinjectors, according to a study presented at the American College of Asthma & Immunology Annual Scientific Meeting.
Lack of patient epinephrine access, education creates need for outreach
LOUISVILLE, Ky. — Only about half of all adults with food allergies have immediate access to epinephrine, according to a study presented at the American College of Asthma & Immunology Annual Scientific Meeting.